Stericycle, Inc. (NASDAQ:SRCL) Downgraded by Zacks Investment Research
Stericycle, Inc. (NASDAQ:SRCL) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Monday.
According to Zacks, “Stericycle reported solid second-quarter 2017 results with a healthy improvement in revenues on a year-over-year basis. The company has a competitive edge with the largest collection and transportation network in the industry, which reduces operating costs and allows it to compete effectively on both service and price perspectives. International growth rates are expected to accelerate due to increasing customer adoption and expansion into new lines of business. In addition, the acquisition pool of the company remains robust in multiple geographies and lines of business. However, low barriers to entry in the industry and stiff competition from local as well as global players significantly reduce its price control. High operating costs continue to be a headwind for Stericycle. In addition, a challenging macroeconomic environment and volatility in foreign exchange are affecting margins. Stericycle also underperformed the industry year to date.”
Several other research firms have also recently weighed in on SRCL. Barclays PLC initiated coverage on shares of Stericycle in a research note on Thursday, April 13th. They issued an “overweight” rating and a $100.00 target price for the company. BidaskClub cut shares of Stericycle from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st. Jefferies Group LLC reissued a “buy” rating and issued a $108.00 target price on shares of Stericycle in a research note on Thursday, July 13th. BMO Capital Markets initiated coverage on shares of Stericycle in a research note on Thursday, June 29th. They issued a “market perform” rating and a $81.00 target price for the company. Finally, Robert W. Baird cut shares of Stericycle from a “neutral” rating to an “underperform” rating and decreased their target price for the company from $74.00 to $73.00 in a research note on Friday, May 5th. Four equities research analysts have rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $81.15.
Shares of Stericycle (NASDAQ SRCL) traded up 0.13% during mid-day trading on Monday, hitting $78.55. 627,074 shares of the stock were exchanged. The company has a market capitalization of $6.70 billion, a PE ratio of 40.93 and a beta of 0.13. Stericycle has a 12-month low of $71.52 and a 12-month high of $90.45. The firm has a 50-day moving average price of $76.84 and a 200 day moving average price of $80.67.
Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, August 3rd. The business services provider reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.13 by $0.02. Stericycle had a negative net margin of 0.07% and a positive return on equity of 14.35%. The business had revenue of $917.70 million during the quarter, compared to analysts’ expectations of $902.81 million. During the same period last year, the business earned $1.18 earnings per share. The firm’s revenue was up 2.9% on a year-over-year basis. On average, equities research analysts expect that Stericycle will post $4.60 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: “Stericycle, Inc. (NASDAQ:SRCL) Downgraded by Zacks Investment Research” was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2017/08/07/stericycle-inc-nasdaqsrcl-downgraded-by-zacks-investment-research.html.
A number of large investors have recently made changes to their positions in the stock. Private Trust Co. NA acquired a new stake in shares of Stericycle during the first quarter valued at about $220,000. Gulf International Bank UK Ltd increased its stake in Stericycle by 1.2% in the first quarter. Gulf International Bank UK Ltd now owns 25,782 shares of the business services provider’s stock worth $2,137,000 after buying an additional 300 shares in the last quarter. Sheets Smith Wealth Management purchased a new stake in Stericycle during the first quarter worth $3,398,000. Douglass Winthrop Advisors LLC purchased a new stake in Stericycle during the first quarter worth $243,000. Finally, Creative Planning increased its stake in Stericycle by 38.5% in the first quarter. Creative Planning now owns 3,483 shares of the business services provider’s stock worth $289,000 after buying an additional 968 shares in the last quarter. 95.16% of the stock is owned by institutional investors and hedge funds.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.